Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Traws Pharma Inc TRAW

Traws Pharma, Inc., formerly Onconova Therapeutics, Inc., is a virology and oncology company. The Company is engaged in developing antivirals for influenza, COVID and other respiratory infections and narazaciclib. Its proprietary portfolio includes, TRX100 (viroksavir), TRX01 (travaltrevir), and Narazaciclib. Viroksavir is a cap-dependent endonuclease inhibitor for influenza. Travaltrevir is a... see more

NDAQ:TRAW - Post Discussion

Traws Pharma Inc > ONTX......sheesh...Higher in pre-market open
View:
Post by Iseneschal on Jun 08, 2021 8:51am

ONTX......sheesh...Higher in pre-market open

Still on watch list

Cheers !
Comment by Iseneschal on Jun 08, 2021 12:40pm
No chasing for me....no position I'm playing "The Waiting Game"  Cheers !
Comment by Iseneschal on Jun 09, 2021 2:08pm
 LMFAO...... "The Waiting Game"..... otherwise known as "Snooze You Loose"... F me.... I knew I was right.  Really peaves me off when I don't listen to myself........ Grrrrrrr  No position.... somebody ...anybody....just kick me where it hurts !!!! Ok... I have vented......back to work!  Cheers !
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities